China's WuXi AppTec In Crosshairs of US Draft Biosecurity Bill

Published 2024-03-24
A draft US law is casting a cloud over some Chinese pharma firms, as it aims to block certain foreign biotech companies from accessing US federal contracts on national security grounds. Bloomberg's Michelle Cortez and Bernstein's Rebecca Liang discuss the implications.

All Comments (14)
  • THERE ARE OVER 2000 AMERICAN COMPANIES OPERATING IN CHINA. THEIR GROSS REVENUE LAST YEAR WAS ALMOST 480 BILLION DOLLARS. AND AMERICAN EXPORTS TO CHINA WAS AROUND 158 BILLION. CURRENTLY CHINA IS WORKING ON LIFTING ANOTHER 300 MILLION CHINESE CITIZENS OUT OF POVERTY. BASED ON EVERY ECONOMIC FACT, CHINA IS THE WORLDS LARGEST CONSUMER MARKET FOR RHE FORDEABLE FEATUR AND THE NEW LEADER IN GLOBAL GDP GROWTH. I AN AMERICAN BUSINESS MAN AND I LOOK AT DATA AND NUMBERS NOT EMOTIONS..THIS COUNTRY IS BECOMING A JOKE.
  • @jjbully
    Losers focus on winners, winners focus on winning
  • @2023gainer
    Global Investors keeping the EV sector charging Up in March. Loading the Dips for Larger Long-term Gains. FSR . Fisker. PSNY.. Polestar. CHPT .. ChargePoint...NIO ..Xos Trucks... Archer.Evtol Jets .ACHR, more
  • @henryliang4989
    she is member of world famous family the ou, but she is marry to my cousin, we own the golden triangle drug trade
  • 5:26 did anyone else catch the Chinese girls admission to giving American men and women life threatening medicines??? Time stamp.
  • @lastChang
    WuXi is an extension of the Chinese 🇨🇳 PLA.